Project Grant R01DA062705
Award Date 9/1/26
Completion Date 6/30/31
Dollars Obligated $358K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Oak Ridge, TN 37830, USA
Similar Awards
- The National Institute on Drug Abuse awarded Rutgers, The State University of New Jersey (RBHS-School of Nursing) $515,211 on July 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct research on post-overdose treatment gaps and prevention opportunities in high-risk youth. The research examines nonfatal drug overdoses in adolescents and young adults to identify barriers to behavioral health treatment connection and to generate evidence for tailored prevention...
- The National Institute on Drug Abuse awarded the University of Rochester $433,029 on March 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and pilot test a novel couples-based treatment intervention for dual substance use disorder in heterosexual couples using opioids and/or stimulants. The project addresses a critical gap in addiction treatment by developing a relational, rather than individual-focused, intervention model tailored to dual-DUD...
- The National Institute on Drug Abuse awarded Johns Hopkins University $198,164 on October 17, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct research examining barriers to medications for opioid use disorder (MOUD) treatment for individuals transitioning from correctional facilities to community settings. The research employs a complex systems approach combining quantitative and qualitative methods. Specific aims include examining the structure and function...
- The National Institute on Drug Abuse awarded the Board of Regents of Nevada System of Higher Education (University of Nevada, Reno) $402,205 on May 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279). The award funds a research study examining medication for opioid use disorder (MOUD) access and treatment outcomes among individuals dually enrolled in Medicare and Medicaid. The research uses Medicare Advantage utilization and prescription claims data from 2021–2024 alongside...
- The National Institute on Drug Abuse awarded The University of Kentucky Research Foundation $548,992 on September 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop county-level prevalence estimates for opioid use disorder using capture-recapture and Bayesian modeling techniques. The research generates opioid use disorder prevalence estimates by county and year using capture-recapture analysis linked to data from multiple participating states, comparing...
- The National Institute on Drug Abuse awarded East Tennessee State University $129,640 on February 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to operate the East Tennessee State University Mentored Substance Use Research (EMSUR) summer program through January 31, 2031. EMSUR will train ten undergraduate students annually over five years through faculty-mentored substance use research, engagement with the digital Substance Use Research Education and Training (SARET)...
- The National Institute on Drug Abuse awarded Rutgers The State University of New Jersey (doing business as RBHS-School of Nursing) $642,253 on August 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct high-precision mapping of sex hormone modulation of reward value computations in opioid addiction. The research addresses disparities in medications for opioid use disorder treatment, which fails in a sizable proportion of patients, particularly female patients...
- The National Institute on Drug Abuse awarded the University of Washington $2,121,054 through the Drug Use and Addiction Research Programs (CFDA 93.279) on September 15, 2025, for a five-year project grant to optimize opioid use disorder treatment strategies in prisons. The research validates two practical, scalable tools for identifying opioid use disorder (OUD) in correctional settings and engaging incarcerated individuals in medication for opioid use disorder (MOUD) treatment. The first tool...
- The National Institute on Drug Abuse awarded The Trustees of Columbia University in the City of New York $1,555,130 on May 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop quantitative evidence informing personalized, sequential medication-for-opioid-use-disorder (MOUD) treatment protocols. The research applies data fusion methodology to synthesize data from seven large MOUD trials conducted by the NIDA Clinical Trials Network, generating evidence-based...
- The National Institute on Drug Abuse awarded $709,085 to The Regents of the University of Colorado, doing business as University of Colorado-Denver, on April 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279). The award funds an implementation trial testing in-hospital opioid treatment program (OTP) intakes to facilitate linkage from hospitalization to outpatient methadone treatment among patients with opioid use disorder. The study uses a staircase cluster randomized...